Concourse Financial Group Securities, Inc. Biotechnology

Concourse Financial Group Securities, Inc.

$0
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
CPRX Catalyst Pharmaceuticals, Inc.	$2.61B	$0 100.0% of portfolio	0	Q1 2025 Sold Out
CVM Cel Sci Corp	$99.3M	$0 100.0% of portfolio	0	Q1 2025 New
CELC Celcuity Inc.	$196M	$0 100.0% of portfolio	0	Q1 2025 New
CLDX Celldex Therapeutics, Inc.	$913M	$0 100.0% of portfolio	0	Q1 2025 New
CLLS Cellectis S.A.	$67.8M	$0 100.0% of portfolio	0	Q1 2025 New
CELUW Celularity Inc Wt Exp 05/24/20	$0	$0 100.0% of portfolio	0	Q1 2025 New
CNTA Centessa Pharmaceuticals PLC	$1.12B	$0 100.0% of portfolio	0	Q1 2025 New
IPSC Century Therapeutics, Inc.	$33M	$0 100.0% of portfolio	0	Q1 2025 New
CSBR Champions Oncology, Inc.	$82.2M	$0 100.0% of portfolio	0	Q1 2025 New
CMMB Chemomab Therapeutics Ltd.	$15.3M	$0 100.0% of portfolio	0	Q1 2025 New
CMRX Chimerix Inc	$748M	$0 100.0% of portfolio	0	Q1 2025 New
CDXC Chroma Dex Corp.	$420M	$0 100.0% of portfolio	0	Q1 2025 New
CINC Cin Cor Pharma, Inc.	$0	$0 100.0% of portfolio	0	Q1 2025 New
CLSD Clearside Biomedical, Inc.	$45.1M	$0 100.0% of portfolio	0	Q1 2025 New
CDXS Codexis, Inc.	$148M	$0 100.0% of portfolio	0	Q1 2025 New
COGT Cogent Biosciences, Inc.	$402M	$0 100.0% of portfolio	0	Q1 2025 New
CGTX Cognition Therapeutics Inc	$7.04M	$0 100.0% of portfolio	0	Q1 2025 New
CHRS Coherus Bio Sciences, Inc.	$63M	$0 100.0% of portfolio	0	Q1 2025 New
CLGN Coll Plant Biotechnologies LTD	$28.5M	$0 100.0% of portfolio	0	Q1 2025 New
CMPX Compass Therapeutics, Inc.	$254M	$0 100.0% of portfolio	0	Q1 2025 New
CGEN Compugen LTD	$152M	$0 100.0% of portfolio	0	Q1 2025 New
CNCE Concert Pharmaceuticals, Inc.	$0	$0 100.0% of portfolio	0	Q1 2025 New
CNTB Connect Biopharma Holdings LTD	$45.1M	$0 100.0% of portfolio	0	Q1 2025 New
CNTX Context Therapeutics Inc.	$9.26M	$0 100.0% of portfolio	0	Q1 2025 New
CFRX Contrafect Corp	$1.18M	$0 100.0% of portfolio	0	Q1 2025 New
CRBP Corbus Pharmaceuticals Holdings, Inc.	$1.04B	$0 100.0% of portfolio	0	Q1 2025 New
CORT Corcept Therapeutics Inc	$7.39B	$0 100.0% of portfolio	0	Q1 2025 New
CRMD Cor Medix Inc.	$568M	$0 100.0% of portfolio	0	Q1 2025 New
CRTX Cortexyme, Inc.	$70.5M	$0 100.0% of portfolio	0	Q1 2025 New
CRVS Corvus Pharmaceuticals, Inc.	$195M	$0 100.0% of portfolio	0	Q1 2025 New
CRNX Crinetics Pharmaceuticals, Inc.	$1.74B	$0 100.0% of portfolio	0	Q1 2025 New
CRSP Crispr Therapeutics Ag	$3.01B	$0 100.0% of portfolio	0	Q1 2025 Sold Out
CUE Cue Biopharma, Inc.	$23M	$0 100.0% of portfolio	0	Q1 2025 New
CGEM Cullinan Oncology, Inc.	$399M	$0 100.0% of portfolio	0	Q1 2025 New
CVAC Cure Vac N.V.	$836M	$0 100.0% of portfolio	0	Q1 2025 New
CYCCP Cyclacel Pharmaceuticals, Inc.	$16.5M	$0 100.0% of portfolio	-	Q1 2025 New
CYTK Cytokinetics Inc	$3.02B	$0 100.0% of portfolio	0	Q1 2025 Sold Out
CTMX Cytom X Therapeutics, Inc.	$171M	$0 100.0% of portfolio	0	Q1 2025 New
DAWN Day One Biopharmaceuticals, Inc.	$511M	$0 100.0% of portfolio	0	Q1 2025 New
DNLI Denali Therapeutics Inc.	$1.91B	$0 100.0% of portfolio	0	Q1 2025 New
DRMA Dermata Therapeutics, Inc.	$7.07M	$0 100.0% of portfolio	0	Q1 2025 New
DRMAW Dermata Therapeutics Inc Wt Ex	$0	$0 100.0% of portfolio	0	Q1 2025 New
DSGN Design Therapeutics, Inc.	$223M	$0 100.0% of portfolio	0	Q1 2025 New
DMAC Dia Medica Therapeutics Inc.	$111M	$0 100.0% of portfolio	0	Q1 2025 New
DYAI Dyadic International Inc	$28.7M	$0 100.0% of portfolio	0	Q1 2025 New
DYN Dyne Therapeutics, Inc.	$737M	$0 100.0% of portfolio	0	Q1 2025 New
EWTX Edgewise Therapeutics, Inc.	$936M	$0 100.0% of portfolio	0	Q1 2025 New
EDIT Editas Medicine, Inc.	$124M	$0 100.0% of portfolio	0	Q1 2025 Sold Out
ELDN Eledon Pharmaceuticals, Inc.	$43.6M	$0 100.0% of portfolio	0	Q1 2025 New
ELEV Elevation Oncology, Inc.	$6.99M	$0 100.0% of portfolio	0	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.